Jones Financial Companies
KURA icon

Jones Financial Companies’s Kura Oncology KURA Stock Holding History

Jones Financial Companies’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Buy
+102
New +$962 ﹤0.01% 4583

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Jones Financial Companies's KURA Position: Q2 2026 in Review

Jones Financial Companies opened a new position in Kura Oncology (KURA) in Q2 2026: 102 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #4583 among its holdings.

220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Jones Financial Companies held 102 shares of Kura Oncology worth $1.11K as of Q2 2026.
  • Kura Oncology was a new Jones Financial Companies position in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4583 holding.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.